Choose your location
Select your country or region to view content specific to your country.
Seeplex® HPV4A ACE Screening can simultaneously detect genotype (HPV 16 and 18) and screen for 16 high-risk types and vaccine related 2 low-risk types (HPV 6/11) from patients’ cervical brush/swab, or liquid-based cytology specimen. (ex.ThinPrep®, specimen transport medium, etc.) This assay enables multiple detection of infected HPV with single specimen based on DPO™ technology.
Key Features and Benefits
-
Multiplex PCR
Simultaneous HPV 16,18 genotyping and 16 high-risk HPV and HPV 6/11 screening
-
Useful monitoring
Useful tool for surveillance and infection control
-
Powerful performance with unique technology
Multiplex PCR with high sensitivity and specificity by utilization of DPO™ technologies
-
Informative assay
Assistant of appropriate treatment and management for co-infection
-
Validated process control
Accurate system for result interpretation included Internal Control
-
Reduction Contamination risk
A single round PCR process and 8-MOP reduces the carryover contamination risk
-
Analytes
-
Specimens
- Liquid based cytology (e.g., ThinPrep® and Surepath™)
- Cervical swab
-
Ordering Information
ProductCat No. / SizeSeeplex® HPV4A ACE ScreeningHP6401Y / 50 rxns
Result
| ID | Result |
|---|---|
| 1 | HRC, HPV 6/11 |
| 2 | HRC, HPV 6/11 |
| 3 | HPV-16, HRC |
| 4 | HRC |
| 5 | HRC |
| 6 | HRC |
| 7 | HRC, HPV 6/11 |
| 8 | HRC, HPV 6/11 |
1~8: Clinical samples
Publication
- Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test.
- Prevalence of human papillomavirus in women from Mexico City.
- Prevalence of human papillomavirus types in cervical intraepithelial lesions
- Frequency of high risk human papillomavirus types in squamous cell carcinoma of cervix among women